Opening Your Study to Places Few Have Gone Before
Clinical trials are more complex than ever. Helping you to create a healthier world for others depends on real solutions that make the most of tight study budgets and timelines. By taking your clinical trial to remote countries and locations, you gain efficiencies that can help create a better clinical environment to help your study succeed.
From the beginning, your clinical trial may benefit from regulatory environments in some regions that allow for faster study startup and rapid enrollment. Furthermore, your study budget may stretch farther in regions where expenses are less, which makes it cost-effective to conduct clinical trials in these areas.
Another benefit is that study screening and enrollment is streamlined due to the availability of patient populations with a high density of specific therapeutic conditions. And unlike study populations in other parts of the world, patients tend to be treatment naïve which means fewer concomitant medication criteria screen failures.
Since our expeditionary CRO service model is built to work with a variety of therapeutic conditions, you now have more possibilities to bring your study to new populations than ever before.